MedPath

Does Selenium Supplementation reduce Oxidative Stress associated with Subarachnoid Haemorrhage? - Selenium and Subarachnoid Haemorrhage

Phase 1
Conditions
Patients with spontaneous subarachnoid haemorrhage (non-traumatic) admitted to the Intensive Vare Unit of the Royal London Hospital.
Registration Number
EUCTR2005-004684-31-GB
Lead Sponsor
Barts and the London NHS Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
0
Inclusion Criteria

Age 18-70
Hunt and Hess (1974) Subarachnoid haemorrhage Grade 3-5
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Preganccy
Pre-existing renal failure
Pre-existing hepatic failure
Participation in other intervention trials in the past 30 days
Refusal of consent from the patient or assent from the next of kin
Foreseeable imminent death

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath